US4318982A
Expired / Lapsed
US
⏱️ 0.0 years remaining
FMN-Labeled specific binding assay
Assignee: Bayer Corp
•
Filing: 1980-11-03
•
Granted: 1982-03-09
•
Expires: 2000-11-03
Abstract
Abstract A specific binding assay for determining a ligand in a liquid medium employing an organic prosthetic group residue, such as a residue of flavin adenine dinucleotide, flavin mononucleotide, or heme, as a label component in the labeled conjugate. Preferably, the label component is the prosthetic group residue alone or is a holoenzyme residue comprising such prosthetic group residue combined with an apoenzyme in the form of a holoenzyme complex. In the former case, the label component preferably is monitored in the assay by adding an apoenzyme after the binding reaction has been initiated and measuring the resultant holoenzyme activity. In the latter case, the label component is monitored simply by measuring holoenzyme activity. The assay method may follow conventional homogeneous and heterogeneous schemes. Preferred apoenzymes for use in the assay are apoglucose oxidase and apoperoxidase. The assay offers the advantages of colorimetric read-out and of being readily adaptable to automated techniques. Also disclosed are prosthetic group-labeled and enzyme-labeled conjugates for use in the assay, as well as a method for preparing the latter conjugates.
Inventors
- 👤 William E. Hornby
- 👤 David L. Morris
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-29 11:21
CPC Classifications
C; C12; C12N; C12N9/00; C12N9/96; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/531; G01N33/532; G01N33/535; G01N33/536; G01N33/542; G01N33/58; G01N33/581; G01N33/74; G01N33/78; Y; Y10; Y10S; Y10S435/00; Y10S435/81; Y10S435/975
Claims Analysis
Total Claims: 20
Claim 1
Independent Claim
158 words
A homogeneous specific binding assay method for determining a ligand in a liquid medium, comprising the steps of: forming a reaction mixture by contacting said liquid medium with (a) reagent means including a labeled conjugate comprising, as label component, flavin mononucleotide coupled to a binding component, such contact producing a binding reaction system in which a bound-species and a free-species of said labeled conjugate are formed, the proportion of the flavin mononucleotide label component in said two formed species being a function of the presence of said ligand in said liquid medium, and (b) an apoenzyme selected from the group consisting of apocytochrome reductase, apoNADPH:oxidoreductase and apopyridoxine phosphate oxidase, the ability of the flavin mononucleotide label component to combine with the apoenzyme to produce a holoenzyme being different in activity in said two formed species, and determining the proportion of the flavin mononucleotide label component in said two formed species by measuring holoenzyme activity in said reaction mixture.
Claim 2
Dependent Claim
158 words
A homogeneous specific binding assay method for determining a ligand in a liquid medium, comprising the steps of: forming a reaction mixture by contacting said liquid medium with (a) reagent means including a labeled conjugate comprising, as label component, flavin mononucleotide coupled to a binding component, such contact producing a binding reaction system in which a bound-species and a free-species of said labeled conjugate are formed, the proportion of the flavin mononucleotide label component in said two formed species being a function of the presence of said ligand in said liquid medium, and (b) an apoenzyme selected from the group consisting of apocytochrome reductase, apoNADPH:oxidoreductase and apopyridoxine phosphate oxidase, the ability of the flavin mononucleotide label component to combine with the apoenzyme to produce a holoenzyme being different in activity in said two formed species, and determining the proportion of the flavin mononucleotide label component in said two formed species by measuring holoenzyme activity in said reaction mixture.
Claim 3
Dependent Claim
20 words
The method of claim 1 wherein said liquid medium is contacted with the apoenzyme after contact with said reagent means.
Claim 4
Dependent Claim
20 words
The method of claim 1 wherein said liquid medium is contacted with said reagent means and the apoenzyme substantially simultaneously.
Claim 5
Dependent Claim
21 words
The method of claim 3 wherein said reagent means and the apoenzyme are contacted with said liquid medium as separate entities.
Claim 6
Dependent Claim
38 words
The method of claim 1 wherein said ligand to be determined is an antigen or an antibody thereto; a hapten or an antibody thereto; or a hormone, vitamin, metabolite or drug, or a receptor or binding substance therefor.
Claim 7
Dependent Claim
120 words
A homogeneous specific binding assay method for determining a ligand in a liquid medium, comprising the steps of: forming a reaction mixture by combining said liquid medium with reagent means including (1) a labeled conjugate comprising, as label component, flavin mononucleotide coupled to said ligand or a binding analog thereof, (2) a specific binding partner of said ligand, and (3) an apoenzyme selected from the group consisting of apocytochrome reductase, apoNADPH:oxidoreductase, and apopyridoxine phosphate oxidase, wherein the binding by said binding partner of said ligand or analog thereof in said labeled conjugate inhibits the ability of the flavin mononucleotide label component to combine with the apoenzyme to produce a holoenzyme; and measuring the resulting holoenzyme activity in said reaction mixture.
Claim 8
Dependent Claim
120 words
A homogeneous specific binding assay method for determining a ligand in a liquid medium, comprising the steps of: forming a reaction mixture by combining said liquid medium with reagent means including (1) a labeled conjugate comprising, as label component, flavin mononucleotide coupled to said ligand or a binding analog thereof, (2) a specific binding partner of said ligand, and (3) an apoenzyme selected from the group consisting of apocytochrome reductase, apoNADPH:oxidoreductase, and apopyridoxine phosphate oxidase, wherein the binding by said binding partner of said ligand or analog thereof in said labeled conjugate inhibits the ability of the flavin mononucleotide label component to combine with the apoenzyme to produce a holoenzyme; and measuring the resulting holoenzyme activity in said reaction mixture.
Claim 9
Dependent Claim
22 words
The method of claim 6 wherein said reaction mixture is incubated for a predetermined period of time prior to measuring holoenzyme activity.
Claim 10
Dependent Claim
23 words
The method of claim 6 wherein said liquid medium is contacted with said labeled conjugate, said binding partner and the apoenzyme substantially simultaneously.
Claim 11
Dependent Claim
34 words
The method of claim 6 wherein said liquid medium is combined first with said labeled conjugate and said binding partner, and after a predetermined incubation period, with the apoenzyme to form said reaction mixture.
Claim 12
Dependent Claim
25 words
The method of claim 6 wherein said ligand to be determined is an antigen or a hapten and said binding partner is an antibody thereto.
Claim 13
Dependent Claim
118 words
In a reagent means for determining a ligand in a liquid medium, which means comprises the reagents of a binding reaction system, including a conjugate having a label component and a binding component, in which reaction system upon contact with said liquid medium are formed a bound-species and a free-species of said labeled conjugate, the proportion of said label component in said two formed species being a function of the presence of said ligand in said liquid medium, the improvement wherein said label component comprises flavin mononucleotide and said means includes an apoenzyme selected from the group consisting of apocytochrome reductase, apoNADPH:oxidoreductase, and apopyridoxine phosphate oxidase, which combines with the flavin mononucleotide label component to produce a holoenzyme.
Claim 14
Dependent Claim
118 words
In a reagent means for determining a ligand in a liquid medium, which means comprises the reagents of a binding reaction system, including a conjugate having a label component and a binding component, in which reaction system upon contact with said liquid medium are formed a bound-species and a free-species of said labeled conjugate, the proportion of said label component in said two formed species being a function of the presence of said ligand in said liquid medium, the improvement wherein said label component comprises flavin mononucleotide and said means includes an apoenzyme selected from the group consisting of apocytochrome reductase, apoNADPH:oxidoreductase, and apopyridoxine phosphate oxidase, which combines with the flavin mononucleotide label component to produce a holoenzyme.
Claim 15
Dependent Claim
21 words
The reagent means of claim 11 wherein said binding component in said conjugate is said ligand or a binding analog thereof.
Claim 16
Dependent Claim
39 words
The reagent means of claim 11 wherein said ligand to be determined is an antigen or an antibody thereto; a hapten or an antibody thereto; or a hormone, vitamin, metabolite or drug, or a receptor or binding substance therefor.
Claim 17
Dependent Claim
86 words
A test kit for determining a ligand in a liquid medium, comprising, (1) a labeled conjugate comprising, as label component, flavin mononucleotide coupled to said ligand or a binding analog thereof, (2) a specific binding partner of said ligand, and (3) an apoenzyme selected from the group consisting of apocytochrome reductase, apoNADPH:oxidoreductase, and apopyridoxine phosphate oxidase, which combines with the flavin mononucleotide label component to produce a holoenzyme wherein the binding partner, the conjugate, and the apoenzyme are present in amounts sufficient to detect the ligand.
Claim 18
Dependent Claim
86 words
A test kit for determining a ligand in a liquid medium, comprising, (1) a labeled conjugate comprising, as label component, flavin mononucleotide coupled to said ligand or a binding analog thereof, (2) a specific binding partner of said ligand, and (3) an apoenzyme selected from the group consisting of apocytochrome reductase, apoNADPH:oxidoreductase, and apopyridoxine phosphate oxidase, which combines with the flavin mononucleotide label component to produce a holoenzyme wherein the binding partner, the conjugate, and the apoenzyme are present in amounts sufficient to detect the ligand.
Claim 19
Dependent Claim
14 words
The test kit of claim 14 which additionally comprises reagents for measuring holoenzyme activity.
Claim 20
Dependent Claim
26 words
The test kit of claim 14 wherein said ligand to be determined is an antigen or a hapten and said binding partner is an antibody thereto.
References Cited (Backward Citations)
US3879262A
Cited
US3998943A
Cited
US3935074A
Cited
US4040907A
Cited
US4230797A
Cited
US4134792A
Cited
US4235869A
Cited
US4238565A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1985-03-08 | 1985-09-07 | 1986-03-09 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1989-03-08 | 1989-09-07 | 1990-03-09 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1993-03-08 | 1993-09-07 | 1994-03-09 | $7700.00 | Window Closed / Lapsed |